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models. A checklist based on critiques of recent HTAs will be a useful tool for manu-
facturers when selecting relevant HRQoL parameters.
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Objectives: The Columbia Suicide Severity Rating Scale (C-SSRS) has been devel-
oped into an electronic self-rated version (the e-CSSRS) in order to facilitate compli-
ance with regulatory requirements for prospective monitoring of suicidal ideation 
and behaviours. The e-CSSRS v2.0 for IVRS has been translated and linguistically 
validated for use in over 60 countries. Whilst translating and linguistically validating 
the scale it was noted that particularly in the Asia-Pacific region there were some 
challenging issues around the concept of suicide from a linguistic and cultural 
perspective. This study aimed to determine what these issues were and highlight 
how they were resolved. MethOds: Eighteen reports were reviewed from the Asia-
Pacific region. The languages were: China-Mandarin, India-English, India-Gujarati, 
India-Hindi, India-Kannada, India-Malayalam, India-Marathi, India-Tamil, India-
Telugu, Korea-Korean, Malaysia-English, Malaysia-Malay, Malaysia-Mandarin, 
Philippines-English, Philippines-Tagalog, Singapore-English, Singapore-Malay, and 
Singapore-Mandarin. Each report was reviewed for challenges relating to translation 
and cultural adaptation. Results: Across all reports specific homonymic confu-
sions were encountered within two target languages: in Indian Hindi the same 
word is used for “pill” and “bullet”; in Singapore Malay the words for “end” and 
“saving” sound similar, occasioning confusion in prompts about attempts to end 
life. Translations were adapted to avoid these confusions. In two cases the use of 
a gun in suicide attempts was found to be rare or unknown: in Singapore English 
the relevant prompt was clarified to minimise confusion; for Malayalam for Kerala, 
where shooting is rare and hanging is common, “getting a gun” was changed to 
“getting a rope” wherever it appeared and for similar reasons “collecting pills” was 
changed to “collecting a poison.” cOnclusiOns: The e-CSSRS v2.0 IVRS is now 
available in for use in over 60 countries. Some issues were identified relating to 
translation and the methods of suicide in a small number of languages but these 
were resolved throughout the linguistic validation process.
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Objectives: Utilities can be easily derived using generic quality of life (QoL) instru-
ments. However, problems in collecting utility scores may occur because clinical 
evaluations still favor disease specific instruments over generic quality of life instru-
ments for reasons of sensitivity and reliability. Especially in case of the fluctuating 
nature of seizures in epilepsy, generic QoL-instruments are often find to be unsuit-
able for outcome research. A proposed method to bridge the gap between clinically 
relevant outcome measures and QoL is to derive utility scores for epilepsy health 
states. The aim of this study is to develop a scoring algorithm to transform epilepsy 
health states into utility scores. MethOds: The proposed scoring algorithm was 
based on valuations of health states generated by the Time Trade-Off (TTO) method. 
The TTO was based on clinically important attributes (seizure frequency, seizure 
severity and treatment related side-effects). A full factorial design was used which 
resulted in 78 scenario’s. Besides standard demographics, every participant was 
asked to value 10 or 11 different health states. A multilevel regression analysis was 
performed to account for the nested structure of the data. The TTO was conducted 
using online survey software. Results: In total 531 subjects of the general popula-
tion, with an average age of 42 years, have participated in the TTO study. Preliminary 
results show that the best health state (no seizures and no side-effects) is estimated 
at 0.89 utility and the worst state (seizures twice a day, many side-effects, type 5 
seizure) is estimated at 0.16. cOnclusiOns: This study provides a scoring algo-
rithm for transforming clinically relevant outcome measures of epilepsy into utility 
estimates which can be incorporated into economic evaluations. Although seizure 
frequency is the most commonly reported primary outcome measure in epilepsy 
research, this study suggest that the impact of seizure severity alone should not 
be underestimated.
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Objectives: Several national health technology assessment (HTA) bodies including 
the National Institute for Health and Care Excellence (NICE) for England and Wales 
recommend EQ-5D as the preferred health-related quality of life (HRQL) measure for 
use in cost-effectiveness analyses. This study aims to evaluate the recommendation 
and impact of using EQ-5D-5L versus EQ-5D-3L for cost-effectiveness modeling in 
HTA submission guidelines and subsequent reimbursement decisions. MethOds: 
A targeted review of national HTA submission modeling guidelines since the intro-
duction of the EQ-5D-5L measure was carried out for the UK and France. The cost-
effectiveness modeling guidelines were assessed for the requirements for EQ-5D at 
either level. The impact of guideline requirements on submissions were analysed 
by examining the presence of EQ-5D-5L in the 20 most recent technical appraisal 
manufacturer submissions for each HTA body. Results: While all HTA bodies rec-
ommended the use of EQ-5D as a generic measure of HRQL, only NICE specifically 
recommended EQ-5D-5L. However, it was not a requirement. Of the latest published 
guidance only NICE and the Scottish Medicines Consortium had one EQ-5D-5L sub-
mission each. Despite evidence suggesting increased sensitivity and reduced ceiling 
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Objectives: To investigate the extent to which two different modes of adminis-
tration (interview by a trained interviewer versus self-administration) yielded a 
comparable estimate of health-related quality of life (HRQL) in pulmonary tuber-
culosis (PTB) patients. MethOds: The study was conducted between September 
1st 2012 and July 31st 2013, among consecutive PTB patients treated at Thoracic and 
Respiratory Disease Specialist Centre in Baghdad, Iraq. The mode of administration 
of the Functional Assessment of Chronic Illness Therapy-Tuberculosis (FACIT-TB); 
a new tuberculosis (TB) -specific instrument, at baseline was registered in 305 sub-
jects. Results: Although the FACIT-TB was designed for self-administration, most 
patients in our sample (N = 193,63.278%) requested some help from the interviewer 
to fill out the questionnaire. Mann Whitney U test showed that those patients capa-
ble of self-administration were younger (38.16 ± 12.93 versus 43.58 ± 16.41 years, p 
= 0.005) and required less time to complete the questionnaire compared to those 
who interviewed by a trained interviewer (14.64 ± 3.24 versus 17.22 ± 2.61 minutes, 
p < 0.001), while Chi-Square statistics showed that this group of patients had a 
higher education level (p < 0.001). No differences in gender were observed. HRQL 
score across all domains for those who interviewed by a trained investigator was 
slightly lower than those who answered the questionnaire by self-administration. 
However, the results did not reach statistical significance (p> 0.05). cOnclusiOns: 
Technical equivalence has been demonstrated in the sample of PTB patients in Iraq. 
FACIT-TB instrument is flexible and it is able to accommodate the needs of patients 
with diverse social, educational, and functional skills. Technical equivalence across 
different modes of administration of questionnaire permits unbiased assessment 
of the impact of the disease and its treatments on patients’ HRQL.
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Objectives: Cancer has the second highest mortality rates after cardiovascular dis-
eases in the world. Advances in treatment options caused significant enhancements 
in survival of cancer patients. However, the major parameter affecting treatment 
success and treatment adherence in these patients is the quality of life (QoL). We 
aimed to develop a self-administered iPad application for evaluation of QoL in a 
short questionnaire. MethOds: As part of routine practice in Preventive Oncology 
Department EORTC QLQ-C30 was administered to 1549 cancer patients treated in 
Hacettepe University Oncology Hospital. We determined 10 questions that explains 
most of the variation in QoL using factor analysis, and designed a new application 
for iPad, where patients can record responses themselves. Results: The 10 factors 
that described by the factor analysis had the power of 74,2% explaining QoL vari-
ances. The reliability analysis of these factors showed a Cronbach alpha coefficient 
of 0,75. The new self-administered iPad application was tested in a pilot study that 
conducted in 127 patients taking chemotherapy regimens in the outpatient setting. 
The validity and reliability analyses revealed that the new application can be effec-
tively used in Turkish cancer patients. cOnclusiOns: Our results revealed that our 
software application will be useful and efficient for monitoring of the changes in 
QoL during their treatment course. Furthermore, this kind of mobile applications 
may be practical for health professionals in daily routine clinical assessments of 
patients. Also, the audio and visual enhancements in electronic applications provide 
increased accessibility for the cancer patients.
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Objectives: Incorporation of health-related quality of life (HRQoL) evidence into 
economic models is a requirement of many countries for the purposes of Health 
Technology Assessment (HTA), and therefore appropriate health state utility values 
(HSUVs) are often sought. The objective of this review was to: (i) identify and sum-
marise the principal limitations of HSUVs used in recent submissions appraised 
by the National Institute for Health and Care Excellence (NICE) and (ii) produce 
a categorical checklist that can be used by manufacturers to reduce uncertainty 
when selecting HSUVs for HTA. MethOds: Evidence appraisal documents for the 
50 most recently published technologies assessed by NICE were retrieved in June 
2014. Economic models were assessed and utility inputs reviewed. Critiques of the 
utilities reported by the evidence review group or final appraisal committee were 
extracted, reviewed and categorised. Results: Of the appraisals reviewed (43 single 
technology appraisals (TAs) and 7 multiple TAs), utility inputs were either sourced 
from the literature (n= 27), published mapping algorithms (n= 11), de novo mapping 
algorithms (n= 2), or derived from clinical trials (n= 10). The concerns expressed by 
review groups can be categorised into four categories: (i) generalisability – relevance 
of HSUVs to UK clinical practice, deviation from NICE scope, and the use of other 
countries’ valuations for health states; (ii) HSUV selection – inadequate justification 
of HSUVs, and lack of consideration for covariates and disutilities; (iii) mapping algo-
rithms – use of non-validated or non-peer-reviewed publications, incomplete report-
ing of key model information, and ambiguity regarding selection and justification 
of mapping function; (iv) risk of bias – sample size, instrument response rates, and 
general study quality identified as factors affecting HSUV validity. cOnclusiOns: 
The selection of appropriate HSUVs is critical to reduce uncertainty in economic 
